Apoglyx Competitors and Similar CompaniesClear all
Apoglyx's competitors and similar companies include Carmot Therapeutics and Enthera Pharmaceuticals.
 Apoglyx Apoglyx is a biotech company developing a small molecule oral therapy for type 2 diabetes patients. |  Carmot Therapeutics Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer. |  Enthera Pharmaceuticals Enthera Pharmaceuticals is a company that develops a biotechnology platform designed to find new therapeutic approaches to treat diabetes and related gastrointestinal complication. | |
Founding Date | Founding Date 2015 | Founding Date 2008 | Founding Date 2016 |
Type | Type Private | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations Malmö, SE HQ Lund, SE | Locations Berkeley, US HQ | Locations Milan, IT HQ Milan, IT Milan, IT |
Employees | Employees 525% increase | Employees 109% decrease | Employees 225% increase |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 74.8m | Total funding raised $ 32.8m |
For sources of this data, please see the company profile
View Company Profiles
Carmot Therapeutics
HQ
Berkeley, US
Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer.
View companyEnthera Pharmaceuticals
HQ
Milan, IT
Employees
22↑ 5% increase
Enthera Pharmaceuticals is a company that develops a biotechnology platform designed to find new therapeutic approaches to treat diabetes and related gastrointestinal complication.
View company